Table 2.

Effect of Glycemic Traits on Myopia

Exposures	SNPs	Methods	OR	95% CI	P *
Adiponectin	13	Inverse variance weighted	0.990	0.984–0.997	2.66 × 10−3
		MR Egger	0.983	0.975–0.992	3.47 × 10−3
		Weighted median	0.989	0.980–0.997	0.01
		Weighted mode	0.987	0.979–0.996	0.01
BMI	145	Inverse variance weighted	0.987	0.980–0.994	5.98 × 10−4
		MR Egger	1.009	0.988–1.031	0.36
		Weighted median	0.992	0.984–1.001	0.08
		Weighted mode	0.992	0.970–1.014	0.51
Fasting blood glucose	22	Inverse variance weighted	1.007	0.995–1.019	0.28
		MR Egger	0.986	0.963–1.009	0.25
		Weighted median	1.007	0.995–1.019	0.24
		Weighted mode	0.998	0.987–1.009	0.73
Fasting insulin	14	Inverse variance weighted	1.007	0.971–1.044	0.70
		MR Egger	0.810	0.690–0.951	0.02
		Weighted median	1.015	0.979–1.052	0.43
		Weighted mode	1.068	0.995–1.147	0.09
HbA1c	213	Inverse variance weighted	1.022	1.011–1.032	3.06 × 10−5
		MR Egger	1.033	1.002–1.066	0.04
		Weighted median	1.012	1.001–1.024	0.03
		Weighted mode	1.008	0.981–1.036	0.57
Proinsulin levels	8	Inverse variance weighted	1.006	0.996–1.015	0.24
		MR Egger	0.995	0.974–1.018	0.69
		Weighted median	1.005	0.996–1.013	0.28
		Weighted mode	0.999	0.990–1.010	0.99

^*Significance was defined as P < 8.3 × 10⁻³.